C

Corat Therapeutics

10 employees

CORAT Therapeutics develops an innovative therapeutic drug composed of a novel fully human neutralizing antibody against COVID-19.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics

Date founded

2020

Funding rounds raised

C

Corat Therapeutics raised undisclosed on July 7, 2021

Investors: Dermapharm AG

FAQ